Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis.
Zrzavy T, Daniels E, Stuka N, Weber D, Winkelmann A, Rauschka H, Hecker M, Aboulenein-Djamshidian F, Meister S, Leutmezer F, Berger T, Bsteh G, Zettl UK, Rommer P.
Zrzavy T, et al. Among authors: winkelmann a.
Ther Adv Chronic Dis. 2021 Jul 28;12:20406223211024366. doi: 10.1177/20406223211024366. eCollection 2021.
Ther Adv Chronic Dis. 2021.
PMID: 34377385
Free PMC article.